scispace - formally typeset
E

Ehab F. Abdo

Researcher at Assiut University

Publications -  7
Citations -  396

Ehab F. Abdo is an academic researcher from Assiut University. The author has contributed to research in topics: Randomized controlled trial & Hydroxychloroquine. The author has an hindex of 3, co-authored 6 publications receiving 160 citations.

Papers
More filters
Journal ArticleDOI

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, +106 more
TL;DR: In this article, a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients was presented.
Posted ContentDOI

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

Cathrine Axfors, +101 more
- 22 Oct 2020 - 
TL;DR: It is found that there is no benefit of hydroxychloroquine or chloroquine on the survival of COVID-19 patients, and the confidence interval is compatible with increased mortality or negligibly reduced mortality.
Journal ArticleDOI

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.

TL;DR: Adding HCQ to standard care did not add significant benefit, did not decrease the need for ventilation, and did not reduce mortality rates in COVID-19 patients, according to univariate logistic regression analysis.
Journal ArticleDOI

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, +106 more